Q4 Platform Voted ‘Favorite New Product: Financial Services' in 2025 American Business Awards
'This honor is especially meaningful because it represents the voice of our most valued audience: our customers,' said Q4 CEO Darrell Heaps. 'We're proud of the impact our AI is having — helping IR teams cut through complexity, uncover insights faster, and focus on what matters most: driving stronger investor relationships and long-term company value. The award celebrates our customers' successes and underscores our commitment to continued AI innovation.'
More than 11,000 votes were cast in the People's Choice portion of the American Business Awards (ABAs) — honoring new solutions and services delivering real-world results.
This recognition also adds to Q4's strong showing at this year's ABAs. Expert judges named the Q4 Platform a winner for 'New Product: Financial Services' and 'New Technology: AI Solution: Financial' — calling it a 'game-changer' and 'impressive AI-driven solution that addresses the complexities of investor relations.'
Transforming IR with AI
These wins come as Q4 further demonstrates how its AI helps IR teams reimagine their workflows and supercharge results. This week at NIRI2025, the premier event for IR professionals, Q4 previewed its latest agentic AI innovation.
To learn more about how Q4's AI, purpose-built for IR, unleashes productivity and strengthens outcomes, please visit the Q4 site.
About Q4 Inc.
Q4 Inc. is the leading provider of IR Ops software with the world's largest set of proprietary investor data, purpose-built to remove obstacles between public companies and their investors. Q4 gives investor relations leaders, C-suite executives, and their teams the tools to attract, manage, and understand investors — all in one place. The AI-enabled Q4 Platform boasts applications for website and event management, engagement analytics, and overall lifecycle management, including AI Earnings Co-Pilot to generate draft scripts based on historical data, and AI earnings call summaries to understand peer sentiment. The Q4 Platform also includes a streamlined investor CRM and shareholder intelligence with enhanced metrics to elevate investor targeting strategies. Q4 delivers the data, insights, and workflows that give IR teams the power to focus on what really matters: strategy, relationships, and driving premium valuations for their companies.
Headquartered in Toronto, with offices in New York and London, Q4 is a trusted partner to more than 2,600 public companies globally, including many of the most respected brands in the world. The company maintains an award-winning culture where team members grow and thrive. Learn more at www.q4inc.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
2 hours ago
- Business Wire
Figma and Motiff Reach Global Settlement in Intellectual Property Protection Lawsuits
SAN FRANCISCO--(BUSINESS WIRE)-- Figma and Motiff announced today that the companies have reached an agreement to resolve their intellectual property disputes in the U.S. and Singapore. Under the settlement agreement, Motiff will cease selling its current Motiff Editor Tool and will not sell any future products derived from it, globally, with the exception of mainland China. In September 2024, Figma filed a U.S. lawsuit for breach of contract and copyright infringement against Motiff and its affiliates. On the same day that Figma filed its U.S. suit, it also sued Motiff in Singapore for copyright infringement and trademark infringement. Figma and Motiff have mutually agreed to settle both lawsuits. Under the settlement agreement, Motiff will cease selling its current Motiff Editor Tool and will not sell any future products derived from it, globally, with the exception of mainland China. In mainland China, Motiff may continue to sell its current Motiff Editor Tool for one year, while it reengineers and redesigns the product. Motiff has also agreed to reimburse Figma's legal expenses. 'Figma is singularly focused on building the best possible product for our users. We welcome fair competition and strongly believe that no one should be allowed to copy our or others' IP to gain an advantage. We are pleased to have reached a global settlement that aligns with Figma's values and allows us to keep building for our customers and community without distraction,' said a Figma spokesperson. 'Motiff is equally pleased to have reached a compromise global settlement with Figma that will allow us to focus our efforts on Motiff's AI 2.0 product. Motiff is committed to bringing AI value to our users,' said a Motiff spokesperson. The agreement took effect on July 23, 2025.
Business Wire
3 hours ago
- Business Wire
New Irish Healthtech Firm Phyxiom Set to Transform Asthma and COPD Management
DUBLIN--(BUSINESS WIRE)-- Phyxiom, a pioneering digital healthcare company, today announced its official launch, bringing transformative technology developed through extensive clinical research led by globally recognised respiratory specialist, Professor Richard Costello (RCSI University of Medicine and Health Sciences and Beaumont Hospital). Built upon groundbreaking studies published in Lancet Respiratory Medicine and validated by health economists, Phyxiom's platform provides clinicians with precise, real-time data to significantly enhance asthma and Chronic Obstructive Pulmonary Disease (COPD) management. Co-founded by experienced tech executive Grace O'Donnell as Chief Executive Officer and healthcare professional Elaine Mac Hale as Clinical Operations Director, along with Prof Costello, Phyxiom is a spin-out company from RCSI. Based on a strong foundational IP portfolio developed under an Enterprise Ireland (EI) Commercialisation Fund award the company has recently achieved EI High Potential Start- Up (HPSU) status. O'Donnell and Mac Hale lead Phyxiom's day-to-day operations, driving forward its mission to revolutionise respiratory healthcare through advanced digital solutions. Professor Richard Costello, Chief Medical Officer at Phyxiom and Professor of Respiratory Medicine at RCSI, explained the science behind the innovation: 'Our research, spanning over a decade, has conclusively demonstrated that digitally-informed treatment significantly reduces medication use, prevents unnecessary hospitalisations, and ultimately lowers healthcare costs. By providing clinicians with objective, real-time insights into lung function and medication adherence, Phyxiom fundamentally improves diagnosis accuracy and treatment outcomes.' Phyxiom's technology is already operational across 13 Health Service Executive (HSE) asthma clinics in Ireland, processing nearly 350 patients to date, with plans to expand further and engage Irish private health insurers in 2025. Grace O'Donnell, CEO, said: 'Elaine and I are incredibly proud to lead this exciting RCSI spin-out company into the commercial market. We are passionate about using Richard's groundbreaking research as the foundation to deliver transformative, patient-centric healthcare solutions, significantly improving quality of life for patients suffering from uncontrolled asthma and COPD.' Elaine Mac Hale, Clinical Operations Director, added: 'Phyxiom seamlessly integrates into existing healthcare systems, ensuring minimal disruption to clinicians' workflows. Our evidence-based approach empowers healthcare providers with the insights needed to deliver personalised, effective, and efficient patient care.' Following its successful Irish rollout, Phyxiom is expanding into the UK market in H1 2026 and plans a US launch in 2027, supported by established partnerships and integration with leading electronic health record systems. Phyxiom's launch marks a significant milestone in Ireland's healthtech landscape, highlighting Irish innovation on the global healthcare stage. Those interested in learning more about Phyxiom, can visit the website here: About RCSI University of Medicine and Health Sciences RCSI University of Medicine and Health Sciences is ranked first in the world for its contribution to UN Sustainable Development Goal 3, Good Health and Well-being, in the Times Higher Education (THE) University Impact Rankings 2025. Founded in 1784 as the Royal College of Surgeons in Ireland with responsibility for training surgeons in Ireland, today RCSI is an innovative, not-for-profit, international university exclusively focused on driving improvements in human health worldwide through education, research and engagement. RCSI is among the top 300 universities worldwide in the World University Rankings (2025) and has been awarded Athena Swan Bronze accreditation for positive gender practice in higher education. In 2026, RCSI will open a new public engagement space, dedicated to health and well-being, at 118 St Stephen's Green in Dublin city centre. The space is designed to engage the public in dialogue about living longer, healthier and happier lives through dynamic events and exhibitions. Our aim is to bridge the gap between health sciences research, professional expertise, and public understanding, empowering people to make informed decisions about their health. Visit the RCSI MyHealth Expert Directory to find the details of our experts across a range of healthcare issues and concerns. Recognising their responsibility to share their knowledge and discoveries to empower people with information that leads them to better health, these clinicians and researchers are willing to engage with the media in their area of expertise.
Business Wire
3 hours ago
- Business Wire
Investcorp Credit Management BDC, Inc. Announces Financial Results for the Quarter Ended June 30, 2025, and Quarterly and Supplemental Distribution
NEW YORK--(BUSINESS WIRE)--Investcorp Credit Management BDC, Inc. (NASDAQ: ICMB) ('ICMB' or the 'Company') announced its financial results today for its fiscal quarter ended June 30, 2025. HIGHLIGHTS On August 7, 2025, the Company's Board of Directors (the 'Board') declared a distribution of $0.12 per share for the quarter ending September 30, 2025, payable in cash on October 9, 2025, to stockholders of record as of September 18, 2025, and a supplemental distribution of $0.02 per share, payable on October 9, 2025, to stockholders of record as of September 18, 2025. During the quarter, ICMB made investments in one new portfolio company and four existing portfolio companies. These investments totaled $19.0 million, at cost. The weighted average yield (at origination) of debt investments made in the quarter was 9.03%. ICMB fully realized its investments in three portfolio companies during the quarter, totaling $9.5 million in proceeds. The internal rate of return on these investments was 32.82%. During the quarter, the Company had net advances of $2.9 million on new and existing delayed draw and revolving credit commitments to portfolio companies. The weighted average yield on debt investments, at fair market value, for the quarter ended June 30, 2025, was 10.57%, compared to 10.95% for the quarter ended March 31, 2025. Net asset value decreased $0.15 per share to $5.27, compared to $5.42 as of March 31, 2025. Net assets decreased by $2.1 million, or 2.71%, during the quarter ended June 30, 2025 compared to March 31, 2025. Portfolio results, as of and for the three months ended June 30, 2025: Total assets $224.1mm Investment portfolio, at fair value $204.1mm Net assets $76.0mm Weighted average yield on debt investments, at fair market value (1) 10.57% Net asset value per share $5.27 Portfolio activity in the current quarter: Number of investments in new portfolio companies during the period 1 Number of portfolio companies invested in, end of period 43 Total capital invested in existing portfolio companies (2) $19.0mm Total proceeds from repayments, sales, and amortization (3) $10.2mm Net investment income before taxes (NII) $0.8mm Net investment income before taxes per share $0.06 Net decrease in net assets from operations ($0.4)mm Net decrease in net assets from operations per share ($0.03) Distributions paid per common share $0.12 (1) Represents average yield on total debt investments weighted by fair market value as of June 30, 2025. The weighted average yield on total debt investments reflected above does not represent actual investment returns to the Company's stockholders. (2) Includes gross advances for delayed draw and revolving credit commitments and PIK interest to existing portfolio companies. (3) Includes gross repayments on existing delayed draw and revolving credit commitments to portfolio companies. Expand Mr. Suhail A. Shaikh said 'We continued to execute our strategy with discipline during the second quarter, generating stable net investment income and maintaining strong credit quality despite a mixed headline environment. Our origination activity picked up late in the quarter, reflecting the strength of our sponsor relationships and our commitment to a highly selective investment approach. As we look ahead, we are encouraged by early signs of momentum and remain focused on repositioning the portfolio for long-term value creation.' The Company's dividend framework provides a quarterly base dividend and may be supplemented, at the discretion of the Board, by additional dividends as determined to be available by the Company's net investment income and performance during the quarter. On August 7, 2025, the Board declared a distribution for the quarter ended September 30, 2025 of $0.12 per share payable on October 9, 2025, to stockholders of record as of September 18, 2025, and a supplemental distribution of $0.02 per share, payable on October 9, 2025, to stockholders of record as of September 18, 2025. This distribution represents a 20.07% yield on the Company's $2.79 share price as of market close on June 30, 2025. Distributions may include net investment income, capital gains and/or return of capital, however, the Company does not expect the dividend for the quarter ending June 30, 2025, to be comprised of a return of capital. The Company's investment adviser monitors available taxable earnings, including net investment income and realized capital gains, to determine if a return of capital may occur for the year. The Company estimates the source of its distributions as required by Section 19(a) of the Investment Company Act of 1940 to determine whether payment of dividends are expected to be paid from any other source other than net investment income accrued for the current period or certain cumulative periods, but the Company will not be able to determine whether any specific distribution will be treated as taxable earnings or as a return of capital until after at the end of the taxable year. Portfolio and Investment Activities During the quarter, the Company made investments in one new portfolio company and four existing portfolio companies. The aggregate capital invested during the quarter totaled $19.0 million, at cost, and the debt investments were made at a weighted average yield of 9.03%. The Company received proceeds of $10.0 million from repayments, sales and amortization during the quarter, primarily related to the realization of American Auto Auction Term Loan, 4L Technologies Term Loan, and RESA Power Equity. During the quarter, the Company had net advances of $2.9 million on new and existing delayed draw and revolving credit commitments to portfolio companies. The Company's net realized, and unrealized gains and losses accounted for a decrease in the Company's net investments of approximately $1.0 million, or $0.07 per share. The total net decrease in net assets resulting from operations for the quarter was $0.4 million, or $0.03 per share. As of June 30, 2025, the Company's investment portfolio consisted of investments in 43 portfolio companies, of which 79.23% were first lien investments and 20.77% were equity, warrants, and other investments. The Company's debt portfolio consisted of 98.50% floating rate investments and 1.50% fixed rate investments. Capital Resources As of June 30, 2025, the Company had $17.3 million in cash, of which $14.4 million was restricted cash, and $29.5 million of unused and available capacity under its revolving credit facility with Capital One, N.A. Subsequent Events Subsequent to June 30, 2025 and through August 13, 2025, the Company invested a total of $0.2 million, at cost, which included investments in two existing portfolio companies. As of August 13, 2025, the Company had investments in 43 portfolio companies. On August 7, 2025, the Board declared a distribution for the quarter ended September 30, 2025 of $0.12 per share payable on October 9, 2025 to stockholders of record as of September 18, 2025, and a supplemental distribution of $0.02 per share, payable on October 9, 2025, to stockholders of record as of September 18, 2025. On August 7, 2025, the Board authorized a new share repurchase program of up to $5 million (the "2025 Stock Repurchase Program") for a one-year period, effective August 7, 2025 and terminating on August 7, 2026. The 2025 Stock Repurchase Program may be suspended or discontinued at any time. Subject to these restrictions, the Company will selectively pursue opportunities to repurchase shares which are accretive to net asset value per share. Investcorp Credit Management BDC, Inc. and Subsidiaries Consolidated Statements of Operations (unaudited) For the three months ended June 30, For the six months ended June 30, 2025 2024 2025 2024 Investment Income: Interest income Non-controlled, non-affiliated investments $ 3,778,683 $ 4,091,556 $ 7,266,885 $ 9,652,889 Non-controlled, affiliated investments (16,912 ) (16,919 ) (1,934 ) 11,911 Total interest income 3,761,771 4,074,637 7,264,951 9,664,800 Payment in-kind interest income Non-controlled, non-affiliated investments 342,127 747,479 762,015 1,361,244 Non-controlled, affiliated investments (243 ) 20,047 21,137 39,600 Total payment-in-kind interest income 341,884 767,526 783,152 1,400,844 Dividend income Non-controlled, non-affiliated investments — — 81,607 54,138 Non-controlled, affiliated investments — — — — Total dividend income — — 81,607 54,138 Payment in-kind dividend income Non-controlled, non-affiliated investments 231,057 204,298 452,742 402,421 Non-controlled, affiliated investments — — — — Total payment-in-kind dividend income 231,057 204,298 452,742 402,421 Other fee income Non-controlled, non-affiliated investments 210,487 72,858 331,511 215,205 Non-controlled, affiliated investments — — — — Total other fee income 210,487 72,858 331,511 215,205 Total investment income 4,545,199 5,119,319 8,913,963 11,737,408 Expenses: Interest expense 1,856,195 1,956,995 3,688,162 4,131,190 Base management fees 851,734 889,715 1,699,770 1,841,514 Income-based incentive fees (118,748 ) — (118,748 ) — Professional fees 277,287 257,800 618,570 612,734 Allocation of administrative costs from Adviser 227,874 241,918 481,897 467,774 Amortization of deferred debt issuance costs 153,824 152,590 307,648 305,181 Amortization of original issue discount - 2026 Notes 17,778 17,778 35,555 35,555 Insurance expense 126,009 127,768 246,511 253,534 Directors' fees 73,500 73,500 150,000 148,657 Custodian and administrator fees 74,000 101,236 148,237 169,267 Other expenses 243,714 118,556 283,887 497,962 Total expenses 3,783,167 3,937,856 7,541,489 8,463,368 Waiver of base management fees (72,026 ) (72,899 ) (146,169 ) (170,330 ) Waiver of income-based incentive fees — — — — Net expenses 3,711,141 3,864,957 7,395,320 8,293,038 Net investment income before taxes 834,058 1,254,362 1,518,643 3,444,370 Income tax expense (benefit), including excise tax expense 229,910 (54,740 ) 310,969 56,906 Net investment income after taxes $ 604,148 $ 1,309,102 $ 1,207,674 $ 3,387,464 Net realized and unrealized gain/(loss) on investments: Net realized gain (loss) from investments Non-controlled, non-affiliated investments $ 2,208,625 $ (1,828,530 ) $ 581,343 $ (1,860,514 ) Non-controlled, affiliated investments — — — (6,239,984 ) Net realized gain (loss) from investments 2,208,625 (1,828,530 ) 581,343 (8,100,498 ) Net change in unrealized appreciation (depreciation) in value of investments Non-controlled, non-affiliated investments (2,852,187 ) 1,221,420 527,662 2,311,028 Non-controlled, affiliated investments (394,884 ) (2,654,138 ) (544,685 ) 2,861,600 Net change in unrealized appreciation (depreciation) on investments (3,247,071 ) (1,432,718 ) (17,023 ) 5,172,628 Total realized gain (loss) and change in unrealized appreciation (depreciation) on investments (1,038,446 ) (3,261,248 ) 564,320 (2,927,870 ) Net increase (decrease) in net assets resulting from operations $ (434,298 ) $ (1,952,146 ) $ 1,771,994 $ 459,594 Basic and diluted: Earnings per share $ (0.03 ) $ (0.14 ) $ 0.12 $ 0.03 Weighted average shares of common stock outstanding 14,419,405 14,401,118 14,416,218 14,399,035 Distributions declared per common share $ 0.12 $ 0.15 $ 0.24 $ 0.30 Expand About Investcorp Credit Management BDC, Inc. The Company is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940. The Company's investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments by targeting investment opportunities with favorable risk-adjusted returns. The Company seeks to invest primarily in middle-market companies that have annual revenues of at least $50 million and earnings before interest, taxes, depreciation, and amortization of at least $15 million. The Company's investment activities are managed by its investment adviser, CM Investment Partners LLC. To learn more about Investcorp Credit Management BDC, Inc., please visit Forward-Looking Statements Statements included in this press release and made on the earnings call for the quarter ended June 30, 2025, may contain 'forward-looking statements,' which relate to future performance, operating results, events and/or financial condition. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'will,' 'may,' 'continue,' 'believes,' 'seeks,' 'estimates,' 'would,' 'could,' 'should,' 'targets,' 'projects,' and variations of these words and similar expressions are intended to identify forward-looking statements. Any forward-looking statements, including statements other than statements of historical facts, included in this press release or made on the earnings call are based upon current expectations, are inherently uncertain, and involve a number of assumptions and substantial risks and uncertainties, many of which are difficult to predict and are generally beyond the Company's control. Investors are cautioned not to place undue reliance on these forward-looking statements. Any such statements are likely to be affected by other unknowable future events and conditions, which the Company may or may not have considered, including, without limitation, changes in base interest rates and the effects of significant market volatility on our business, our portfolio companies, our industry and the global economy. Accordingly, such statements cannot be guarantees or assurances of any aspect of future performance or events. Actual results may differ materially from those anticipated in any forward-looking statements as a result of a number of factors and risks. More information on these risks and other potential factors that could affect actual events and the Company's performance and financial results, including important factors that could cause actual results to differ materially from plans, estimates or expectations included herein or discussed on the earnings call, is or will be included in the Company's filings with the Securities and Exchange Commission, including in the 'Risk Factors' and 'Management's Discussion and Analysis of Financial Condition and Results of Operations' sections of the Company's Transition Report on Form 10-KT and Quarterly Reports on Form 10-Q. All forward-looking statements speak only as of the date they are made. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law.
